COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,704 Articles (22,913 medRxiv, 8,791 bioRxiv)

Most recent first Previous |  Page 824: Articles 8231-8240  | Next

Neutralization Escape by the SARS-CoV-2 Omicron Variants BA.2.12.1 and BA.4/BA.5
Hachmann, N., Miller, J., Collier, A.-r., Ventura, J., Yu, J., Rowe, M., Bondzie, E., Powers, O., Surve, N., Hall, K., Barouch, D. H.
10.1101/2022.05.16.22275151 — Posted: 2022-05-19
Fear of Infection and Sufficient Vaccine Reservation Information Might Drive Rapid Coronavirus Disease 2019 Vaccination in Japan: Evidence from Twitter Analysis
Niu, Q., Liu, J., Kato, M., Aoyama, T., Nagai-Tanima, M.
10.1101/2022.05.15.22275071 — Posted: 2022-05-19
COVID-19 booster dose antibody response in pregnant, lactating, and nonpregnant women
Atyeo, C., Shook, L. L., Nziza, N., DeRiso, E. A., Muir, C., Medina Baez, A., Lima, R. S., Demidkin, S., Brigida, S., De Guzman, R. M., Burns, M. D., Balazs, A. B., Fasano, A., Yonker, L. M., Gray, K. J., Alter, G., Edlow, A. G.
10.1101/2022.05.17.22275154 — Posted: 2022-05-19
Self-medication practices and associated factors among COVID-19 recovered patients to prevent future infections: A web-based survey in Bangladesh
Sujan, M. S. H., Haghighathoseini, A., Tasnim, R., Islam, M. S., Salauddin, S. M., Hasan, M. M., Uddin, M. R.
10.1101/2022.05.14.22275075 — Posted: 2022-05-19
Reduced antibody acquisition with increasing age following vaccination with BNT162b2: results from a large study performed in the general population aged 12 to 92 years
van den Hoogen, L. L., Boer, M. C., Postema, A., de Rond, L., de Zeeuw-Brouwer, M.-l., Pronk, I., Wijmenga-Monsuur, A. J., Bijvank, E., Kruiper, C., Beckers, L., Bogaard-van Maurik, M., Zutt, I., van Vliet, J., van Bergen, R., Kuijer, M., Smits, G., Verschuren, W. M. M., Picavet, H. S. J., van der Klis, F. R. M., den Hartog, G., van Binnendijk, R. S., Buisman, A.-M.
10.1101/2022.05.18.22275209 — Posted: 2022-05-19
Analytical performance of rapid antigen tests for the detection of SARS-CoV-2 during widespread circulation of the Omicron variant
Suzuki, H., Akashi, Y., Kato, D., Takeuchi, Y., Kiyasu, Y., Terada, N., Kurihara, Y., Kuwahara, M., Muramatsu, S., Ueda, A., Notake, S., Nakamura, K.
10.1101/2022.05.17.22275034 — Posted: 2022-05-19
Real-world comparative effectiveness of mRNA-1273 and BNT162b2 vaccines among immunocompromised adults in the United States
Mues, K. E., Kirk, B., Patel, D. A., Gelman, A., Chavers, S., Talarico, C., Esposito, D. B., Martin, D., Mansi, J., Chen, X., Gatto, N. M., Van de Velde, N.
10.1101/2022.05.13.22274960 — Posted: 2022-05-19
Real-World Effectiveness of Casirivimab and Imdevimab Among Patients Diagnosed With COVID-19 in the Ambulatory Setting: A Retrospective Cohort Study Using a Large Claims Database
Hussein, M., Wei, W., Mastey, V., Sanchez, R. J., Wang, D., Murdock, D. J., Hirshberg, B., Weinreich, D. M., Jalbert, J. J.
10.1101/2022.05.19.22272842 — Posted: 2022-05-19
Preceding anti-spike IgG levels predicted risk and severity of COVID-19 during the Omicron-dominant wave in Santa Fe city, Argentina
Eberhardt, A., Simoncini, M., Pina, C., Galoppo, G., Parachu-Marco, V., Racca, A., Arce, S., Viotto, E., Facelli, F., Valli, F., Botto, C., Scarpa, L., Junges, C., Palavecino, C., Beccaria, C., Sklar, D., Mingo, G., Genolet, A., Munoz-de-Toro, M., Aimar, H., Bossio, J. C., Armando, G., Fernandez, H., Beldomenico, P. M.
10.1101/2022.05.18.22275138 — Posted: 2022-05-19
SARS-CoV-2 Subunit Virus-Like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study
Vakhrusheva, A. V., Kudriavtsev, A. V., Kryuchkov, N. A., Deev, R. V., Frolova, M. E., Blagodatskikh, K. A., Djonovic, M., Nedorubov, A. A., Odintsova, E., Ivanov, A. V., Romanovskaya-Romanko, E. A., Stukova, M. A., Isaev, A. A., Krasilnikov, I. V.
10.1101/2022.05.18.492452 — Posted: 2022-05-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).